Skip to content
Biodatica
Start free

Investigator

Yow-Pin Lim

PROTHERA BIOLOGICS, LLC · funded by NICHD, NIAID

Companies
2

Resolved onto their grants.

Grants
3

Federal awards on file.

Non-dilutive funding
$2.0M

Summed across those awards.

First award
Aug 15, 2018

Latest Sep 22, 2023.

Companies from this work

Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.

Grant record

Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.

  1. R43

    Inter-alpha Inhibitors in Experimental Necrotizing Enterocolitis

    $50k

    Sep 22, 2023NICHDPROTHERA BIOLOGICS, LLCNIH RePORTER · 11255387 (opens the source filing in a new tab)

  2. R44

    Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis

    $971k

    Aug 15, 2018NIAIDPROTHERA BIOLOGICS, LLCNIH RePORTER · 11076833 (opens the source filing in a new tab)

  3. R44

    Rapid Test to Assist Therapy in Neonatal Sepsis and Necrotizing Enterocolitis

    $954k

    Aug 15, 2018NIAIDPROTHERA BIOLOGICS, LLCNIH RePORTER · 11324963 (opens the source filing in a new tab)

This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources